A genetic test routinely carried out to help avoid severe and potentially fatal side effects from chemotherapy has now ...
Myriad Genetics Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that ...
The condition makes baby Mack the second baby worldwide to be diagnosed with the condition while still in the womb.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results